Nt‐proBNP in haemodialysis patients: A preliminary study

References

• Tsutamoto T., Wada A., Maeda K., Hisanaga T., Mabuchi N., Hayashi M., et al. Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction. Eur Heart J 1999; 20: 1799–807
   PubMed Web of Science ®Google Scholar
• Maisel A. S., Krishnaswamy P., Nowak R. M., McCord J., Hollander J. E., Duc P., et al. Rapid measurement of B‐type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002; 347: 161–7
   PubMed Web of Science ®Google Scholar
• Omland T., Persson A., Ng L., O'Brien R., Karlsson T., Herlitz J., et al. N‐terminal pro‐B‐type natriuretic peptide and long‐term mortality in acute coronary syndromes. Circulation 2002; 16: 2916–18
   Google Scholar
• Hunt P. J., Richards A. M., Nicholls M. G., Yandle T. G., Dougthy R. N., Espiner E. A. Immunoreactive amino‐terminal pro‐brain natriuretic peptide (NT‐PROBNP): a new marker of cardiac impairment. Clin Endocrinol 1997; 47: 287
   PubMed Web of Science ®Google Scholar
• Harrison A., Morrison L. K., Krishnasamy P., Clopton P., Dao Q., Hlavin P., et al. B‐type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea. Ann Emerg Med 2002; 39: 131–8
   PubMed Web of Science ®Google Scholar
• Maisel A., Koon J., Krishnasamy P., Kazenegra R., Clopton P., Gardetto N., et al. Utility of B‐natriuretic peptide as a rapid, point‐of‐care test for screening patients undergoing echocardiography to determine left ventricular dysfunction. Am Heart J 2001; 141: 367–74
   PubMed Web of Science ®Google Scholar
• Palmieri V., Okim P. M., Bella J. N., Gerts E., Wachtell K., Gardin J., et al. Echocardiographic wall motion abnormalities in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study. Hypertension 2003; 41: 75–82
   PubMed Web of Science ®Google Scholar
• Mair J., Hammerer‐Lercher A., Puschendorf B. The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure. Clin Chem Lab Med 2001; 39: 571–88
   PubMed Web of Science ®Google Scholar
• Ala‐Kopsala M., Magga J., Peuhkurinen K., Leipälä J., Ruskoaho H., Leppäluoto J., et al. Molecular heterogeneity has a major impact on the measurement of circulating N‐terminal fragments of A‐ and B‐type natriuretic peptides. Clin Chem 2004; 50: 1576–88
   PubMed Web of Science ®Google Scholar
• McCullough P. A., Omland T., Maisel A. S. B‐type natriuretic peptides: a diagnostic breakthrough for clinicians. Rev Cardiovasc Med 2003; 4: 72–80
   PubMedGoogle Scholar
• McCullough P. A., Duc P., Omland T., McCord J., Nowak R. M., Hollander J. E., et al. B‐type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly Multinational Study. Am J Kidney Dis 2002; 40: 974–82
   PubMedGoogle Scholar
• Luchner A., Hengstenberg C., Lowel H., Trawinski J., Baumann M., Riegger G. A., et al. N‐terminal probrain natriuretic peptide after myocardial infarction: a marker of cardio‐renal function. Hypertension 2002; 39: 99–104
   PubMed Web of Science ®Google Scholar
• Iwashima Y., Horio T., Takami Y., Inenaga T., Nishikimi T., Takishita S., et al. Effects of the creation of arteriovenous fistula for hemodialysis on cardiac function and natriuretic levels in CRF. Am J Kidney Dis 2002; 40: 974–82
   PubMed Web of Science ®Google Scholar
• Dautin G., Boudjeltia S., Soltani Z., Gambert P., Duvillard L. The changes in NT‐proBNP plasma concentrations during dialysis are highly dependent on the dialysis membrane ultrafiltration coefficient. Clin Chim Acta 2007; 376: 237–9
   PubMedGoogle Scholar
• Cataliotti A., Malitino L. S., Jougasaki M., Zoccali C., Castellino P., Giacone G., et al. Circulating natriuretic peptide concentrations in patients with end‐stage renal disease: role of brain natriuretic peptide as a biomarker for ventricular remodeling. Mayo Clin Proc 2001; 79: 1111–19
   Google Scholar
• Zoccali C., Mallamaci F., Benedetto F. A., Tripepi G., Parlongo S., Cataliotti A., et al. Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients. J Am Soc Nephrol 2001; 12: 1508–15
   PubMed Web of Science ®Google Scholar
• Apple F. S., Murakami M. A. M., Pearce L. A., Herzog C. A. Multi‐biomarker risk stratification of N‐Terminal Pro‐B‐type Natriuretic Peptide, high‐sensitivity C‐Reactive Protein, and Cardiac Troponin T and I in end‐stage renal disease for all cause death. Clin Chem 2004; 50: 2279–85
   PubMed Web of Science ®Google Scholar
• Racek J., Králová H., Trefil L., Rajdl D., Eiselt J. Brain natriuretic peptide and N‐terminal proBNP in chronic haemodialysis patients. Nephron Clin Pract 2006; 103: 62–72
   Google Scholar
• Sahn D., de Maria A., Kisslo J., Wayman A. The committee on M‐mode standardization of the American Society of Echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072–83
   PubMed Web of Science ®Google Scholar
• Devereux R., Koren M., de Simone G., Okin P. M., Klingfield P. Methods for detection of left ventricular hypertrophy: application to hypertensive heart disease. Eur Heart J 1993; 14: 8–15
   PubMed Web of Science ®Google Scholar
• Teichholz L. E., Kreulen T., Herman M. V., Gorlin R. Problems in echocardiographic volume determinations: echocardiographic‐angiographic correlations in the presence or absence of asynergy. Am J Cardiol 1976; 37: 7
   PubMed Web of Science ®Google Scholar
• Madsen L. H., Ladefoged S., Corell P., Schou M., Hildebrandt P. R., Atar D. N‐terminal pro brain natriuretic peptide predicts mortality in patients with end‐stage renal disease in hemodialysis. Kidney Int 2007; 71: 548–54
   PubMed Web of Science ®Google Scholar
• DeFilippi C. R., Fink J. C., Nass C. M., Chen H., Christenson R. N‐terminal pro‐B‐type natriuretic peptide for predicting coronary disease and left ventricular hypertrophy in asymptomatic CKD not requiring dialysis. Am J Kidney Dis 2005; 46: 35–44
   PubMed Web of Science ®Google Scholar
• Osajima A., Okazaki M., Tamura M., Anai H., Kabashima N., Suda T., et al. Comparison of plasma levels of mature adrenomedullin and natriuretic peptide as marker of cardiac function in hemodialysis patients with coronary artery disease. Nephron 2002; 92: 832–9
   PubMedGoogle Scholar
• Mallamaci F., Zoccali C., Tripepi G., Benadetto F. A., Parlongo S., Cataliotti A., et al. Diagnostic potential of cardiac natriuretic peptides in dialysis patients. Kidney Int 2001; 59: 1559–66
   PubMed Web of Science ®Google Scholar
• Groenning B. A., Nilsson J. N., Sondergaard L., Pedersen F., Trawinski J., Baummann M., et al. Detection of left ventricular enlargement and impaired systolic function with plasma N‐terminal pro brain natriuretic peptide concentrations. Am Heart J 2002; 143: 923–9
   PubMed Web of Science ®Google Scholar
• Luchner A., Hengstenberg C., Löwel H., Riegger G. A., Schunkert H., Holmer S. Effect of compensated renal dysfunction on approved heart failure markers: direct comparison of brain natriuretic peptide (BNP) and N‐terminal pro‐BNP. Hypertension 2005; 46: 118–23
   PubMedGoogle Scholar
• Clerico A., Caprioli S., Del Ry S., Giannessi D. Clinical relevance of cardiac natriuretic peptides measured by means of competitive and non‐competitive immunoassay methods in patients with renal failure on chronic hemodialysis. J Endocrinol Invest 2001; 24: 24–30
   PubMedGoogle Scholar
• McGregor D. O., Buttimore A. L., Lynn K. L., Yandle T., Nicholls M. G. Effects of long and short hemodialysis on endothelial function: a short‐term study. Kidney Int 2003; 63: 709–15
   PubMedGoogle Scholar
• Lowbeer C., Gutierrez A., Gustafsson S. A., Norrman R., Hulting J., Seeberger A. Elevated cardiac troponin T in peritoneal dialysis patients is associated with CRP and predicts all‐cause mortality and cardiac death. Nephrol Dial Transplant 2002; 7: 2178–83
   Google Scholar
• Iseki K., Tozawa M., Yoshi S., Fukiyama K. Serum C‐reactive protein (CRP) and risk of death in chronic dialysis patients. Nephrol Dial Transplant 1999; 14: 1956–60
   PubMed Web of Science ®Google Scholar
• Apple F. S., Murakami M. M., Pearce L. A., Herzog C. A. Predictive value of cardiac troponin I and T for subsequent death in end‐stage renal disease. Circulation 2002; 106: 2941–5
   PubMed Web of Science ®Google Scholar
• Fernandez‐Reyes M. J., Mon C., Heras M., Guevara P., Garcia M. C., Sanchez R., et al. Predictive value of troponin T levels for ischemic heart disease and mortality in patients on hemodialysis. J Nephrol 2004; 17: 721–7
   PubMed Web of Science ®Google Scholar
• Sommerer C., Beimler J., Schwenger V., Heckele N., Katus H. A., Giannitsis E., et al. Cardiac biomarkers and survival in haemodialysis patients. Eur J Clin Invest 2007; 37: 350–6
   PubMed Web of Science ®Google Scholar